The first result offering a safe, ready-to-use and cost-effective solution for Covid-19 treatment, Ertugliflozin is an FDA approved drug for type-2 diabetes.
The developed synthetic process technology is cost effective and eco-friendly which uses less solvents and easy to isolate the target molecule in large quantities